Wang Yan, Wu Huimin, Xu Feng
Department of Pharmacy, Fengxian Hospital, Southern Medical University, Shanghai 201400, China ; Department of Pharmacy, Guangdong Medical University Affiliated Hospital, Zhanjiang 524001, China.
Department of Pharmacy, Fengxian Hospital, Southern Medical University, Shanghai 201400, China.
Biomed Res Int. 2015;2015:502431. doi: 10.1155/2015/502431. Epub 2015 Nov 30.
This study was to evaluate the efficacy of pharmaceutical intervention (PI) on chemotherapy knowledge-attitude-practice (KAP) and quality of life (QOL) in cancer patients. A prospective, randomized, controlled study was carried out at Oncology Ward in a tertiary hospital affiliated to Southern Medical University, China. Eligible patient was randomly assigned to pharmaceutical intervention (PI) group or control group. Each patient in PI group was given information booklets and was given 30 min face-to-face medication education and psychological counseling by clinical pharmacists, 2 sessions per week for 2 months. Patients in control group only received conventional treatment. All participants were asked to complete a structured Chemotherapy KAP Questionnaire and QOL Questionnaire at pre- and poststudy time. A total of 149 cancer patients (77 in PI group and 72 in control group) completed the study. The baseline scores of KAP and QOL in 2 groups were similar. At the end of study, only knowledge score was significantly increased; meanwhile no difference existed for attitude, practice, and QOL scores in control group; both KAP scores and QOL score were significantly increased in PI group. As for the between-group comparison, both KAP scores and QOL score in PI group were significantly higher than those in control group. In conclusion, pharmaceutical intervention has a positive role in increasing chemotherapy-related knowledge, improving patients' positive emotions, dealing with chemotherapy adverse reactions, and improving the quality of life of patients.
本研究旨在评估药物干预(PI)对癌症患者化疗知识-态度-实践(KAP)及生活质量(QOL)的影响。在中国南方医科大学附属三级医院的肿瘤科病房开展了一项前瞻性、随机对照研究。符合条件的患者被随机分配至药物干预组或对照组。药物干预组的每位患者均获发信息手册,并由临床药师进行每周2次、每次30分钟、为期2个月的面对面用药教育及心理咨询。对照组患者仅接受常规治疗。所有参与者均被要求在研究前后完成一份结构化的化疗KAP问卷及QOL问卷。共有149例癌症患者(药物干预组77例,对照组72例)完成了研究。两组的KAP及QOL基线评分相似。研究结束时,仅知识评分显著提高;同时,对照组的态度、实践及QOL评分无差异;药物干预组的KAP评分及QOL评分均显著提高。组间比较显示,药物干预组的KAP评分及QOL评分均显著高于对照组。总之,药物干预在增加化疗相关知识、改善患者积极情绪、应对化疗不良反应及提高患者生活质量方面具有积极作用。